European aquaculture is making steady progress towards genetically resistant fish , combining classical selection, next-generation genomics, and precision editing. The goal is significant: to strengthen animal health and welfare, stabilize production, and reduce the use of treatments, especially in key species such as Atlantic salmon.
Based on recent results presented by teams from Norway, the United Kingdom, and the Netherlands , and supported by research in South America, a roadmap is being consolidated that is of direct interest to Spain and the rest of Europe: understanding the genetic basis of resistance, rigorously validating each edit, and fitting these advances into clear and predictable regulatory frameworks.
What does it mean to build more resilient fish?
Building more robust animals combines genomic selection and editing tools like CRISPR to accelerate changes that would traditionally take many generations. The key lies in identifying variants with a real effect on resistance and manipulating them precisely, either through breeding programs or targeted gene editing.
A concrete example is the pangenomics of coho salmon, which has revealed structural variation associated with domestication and traits of productive interest. In a large set of samples, 557 nuclear genes, more than 7.000 variable genes, 152 megabases of new sequences, and 436 previously undescribed genes were detected, opening the door to more comprehensive genomic references for aquaculture.
Furthermore, integrated analysis of whole genomes and transcriptomes is yielding shortlists of candidates with pleiotropy —that is, variants that influence both resistance and growth. In a study with 1.200 genomes and 85 individuals evaluated by RNA-seq, the focus was narrowed down to 28 genes, three of which exhibited specific allelic expression. This advance allows for selection or editing with simultaneous health and production objectives.
To scale up editing, the industry is exploring automation of embryo microinjection and reproducible workflows. The overall message from the sector is clear: editing does not replace selection; it enhances it where selection falls short or where biological timing is a barrier.
Sea lice and immune pathways in salmonids
Sea lice remain the greatest health and economic challenge for salmonids. Comparative studies show that species such as coho and pink salmon mount early and effective immune responses against the ectoparasite, while Atlantic salmon are initially unable to prevent strong attachment.
Using proteomics, spatial transcriptomics, and nuclear RNA sequencing, researchers have identified thousands of genes involved in the fish-parasite interaction, as well as louse proteins capable of modulating host immunity. Cell-scale mapping of the adhesion zone allows researchers to observe gene activation precisely where the immune response occurs.
Based on this information, candidates for CRISPR trials have been prioritized. Modifying genes such as SOX3, the mannose receptor, or cadherin-26 altered the infestation dynamics, reinforcing the crucial role of neutrophils in both destroying the parasite and weakening its attachment point in the skin.
The operational goal is to transfer some of this natural resistance to Atlantic salmon , either through selection based on immune phenotypes or through precise gene editing. The next phase involves validating pure-edited lines and using diagnostic tools such as RNA-scope to confirm the mechanism.
For Europe, where Lepeophtheirus salmonis is also a concern, these findings provide an applicable basis: knowing the immune pathways that work in resistant species allows for the design of strategies adapted to the predominant parasites in the North Atlantic.
Validation, key diseases and European regulations
If the edit is to reach the farm, it must be accompanied by exhaustive controls . European industries are applying high-throughput methodologies based on capture-seq to detect accidental insertions, off-targets, and potential plasmid contamination, demonstrating that pre-commercial validation is non-negotiable.
The technical recommendation is to integrate reproducible bioinformatics pipelines and robust reference assemblies to evaluate each editing event. Recent forums have highlighted that requiring individual-by-individual analysis for thousands of animals may be impractical, but also that transparency and traceability are essential for gaining regulatory and public trust.
Meanwhile, applied genomics continues to gather evidence against relevant pathogens . In Atlantic salmon, regions associated with BKD have been identified using GWAS; in rainbow trout, genotype-vaccine interaction models identify QTLs and candidate genes for IPNv resistance; and in coho salmon, a robust QTL linked to SRS on chromosome 21 has been validated , with plans to test the function of key genes in edited cell lines.
The regulatory debate in Europe is increasingly distinguishing between transgenesis and genetically edited organisms without integrated exogenous DNA. Although regulatory timelines differ between countries, experts anticipate a 5- to 10-year window for seeing products at scale, contingent upon evidence of safety and clear benefits in animal welfare and health.
With Spain closely monitoring developments within the EU framework, the decisive factors will be regulatory clarity , honest communication, and a focus on traits with high health impact. Public acceptance improves when it is demonstrated that an edited fish is safe, contributes to animal welfare, and reduces the need for treatments.
Everything points to an ecosystem where science and regulation converge: with more complete pangenomes , refined lists of candidate genes and robust validation protocols, Europe and Spain are positioning themselves to turn genetic resistance into a tangible tool that strengthens health, productivity and sustainability in aquaculture.
